MedTrace Logo

A Guided Imagery Tobacco Cessation Intervention Delivered by a Quit Line and Website

NCT02968381 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2022-06-22

Study results available
· View outcomes & findings →

Summary

Tobacco use is still the leading cause of preventable disease and death in the United States. Tobacco quit lines are effective at helping smokers to quit, but quit lines are underutilized, especially by men and racial/ethnic minorities. Guided imagery is effective at helping people quit smoking, and is appealing to males and diverse racial groups, but has limited reach. The proposed study will develop and test the feasibility and acceptability of a guided imagery tobacco cessation intervention that is delivered by a combination of quit line coaches and an interactive website. The investigators hypothesize that guided mental imagery delivered using the quit line "coaching model" combined with an interactive website could be an effective intervention strategy.

Conditions

  • Tobacco Use
  • Smoking Cessation
  • Smoking, Tobacco
  • Tobacco Smoking
  • Guided Imagery

Interventions

BEHAVIORAL

Imagery Intervention

Telephone coaching sessions, use of guided imagery and website.

BEHAVIORAL

Control Condition

Telephone coaching using standard cognitive behavioral methods

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • West Virginia University

    collaborator OTHER

  • University of Arizona

    lead OTHER

Principal Investigators

  • Judith Gordon, PhD · University of Arizona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2020-09-29
Completion
2022-01-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02968381 on ClinicalTrials.gov